Interaction of Differently Coated Silver Nanoparticles With Skin and Oral Mucosal Cells.


Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
05 2021
Historique:
received: 17 12 2020
revised: 20 01 2021
accepted: 28 01 2021
pubmed: 5 2 2021
medline: 22 6 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

Silver nanoparticles (AgNP) can be found in different consumer products and various medical devices due to their excellent biocidal properties. Despite extensive scientific literature reporting biological effects of AgNP, there is still a lack of scientific evidence on how different surface functionalization affects AgNP interaction with the human skin and the oral epithelium. This study aimed to investigate biological consequences following the treatment of HaCaT and TR146 cells with AgNP stabilized with negatively charged sodium bis(2-ethylhexyl)-sulfosuccinate (AOT), neutral polyvinylpyrrolidone (PVP), and positively charged poly-l-lysine (PLL). All AgNP were characterized by means of size, shape and surface charge. Interactions with biological barriers were investigated in vitro by determining cell viability, particle uptake, oxidative stress response and DNA damages following AgNP treatment. Results showed a significant difference in cytotoxicity depending on the surface coating used for AgNP stabilization. All three types of AgNP induced apoptosis, oxidative stress response and DNA damages in cells, but AOT- and PVP-coated AgNP exhibited lower toxicity than positively charged PLL-AgNP. Considering the number of data gaps related to the safe use of nanomaterials in biomedicine, this study highlights the importance of particle surface functionalization that should be considered during design and development of future AgNP-based medical products.

Identifiants

pubmed: 33539871
pii: S0022-3549(21)00072-1
doi: 10.1016/j.xphs.2021.01.030
pii:
doi:

Substances chimiques

Silver 3M4G523W1G
Povidone FZ989GH94E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2250-2261

Informations de copyright

Copyright © 2021 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Auteurs

Krunoslav Ilić (K)

Institute for Medical Research and Occupational Health, Zagreb, Croatia.

Sonja Hartl (S)

Department of Pharmaceutical Technology and Biopharmacy, University of Graz, Institute of Pharmaceutical Sciences, Graz, Austria.

Emerik Galić (E)

Faculty of Agrobiotechnical Sciences, J.J. Strossmayer University of Osijek, Osijek, Croatia.

Carolin Tetyczka (C)

Department of Pharmaceutical Technology and Biopharmacy, University of Graz, Institute of Pharmaceutical Sciences, Graz, Austria.

Barbara Pem (B)

Institute for Medical Research and Occupational Health, Zagreb, Croatia.

Rinea Barbir (R)

Institute for Medical Research and Occupational Health, Zagreb, Croatia.

Mirta Milić (M)

Institute for Medical Research and Occupational Health, Zagreb, Croatia.

Ivana Vinković Vrček (I)

Institute for Medical Research and Occupational Health, Zagreb, Croatia.

Eva Roblegg (E)

Department of Pharmaceutical Technology and Biopharmacy, University of Graz, Institute of Pharmaceutical Sciences, Graz, Austria.

Ivan Pavičić (I)

Institute for Medical Research and Occupational Health, Zagreb, Croatia. Electronic address: ipavicic@imi.hr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH